Tactile Systems Technology, Inc.

TCMD ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $19.1M $17.0M $28.5M $-17.9M $-11.8M $-620.0K $11.0M $6.6M
Depreciation & Amortization $6.6M $6.8M $6.5M $6.3M $3.7M $2.8M $3.5M $3.7M
Depreciation $2.9M $3.0M $2.7M $2.5M $2.3M $2.4M $3.0M $3.3M
Amortization $3.7M $3.8M $3.8M $3.8M $1.4M $400.0K $500.0K $400.0K
Stock-Based Compensation $8.4M $7.8M $7.5M $9.6M $10.2M $10.7M $9.8M $8.0M
Net Cash from Operating Activities $42.8M $40.7M $35.9M $5.2M $2.6M $2.8M $2.5M $9.0M
Investing Activities
Capital Expenditures $2.4M $2.4M $2.3M $1.8M $2.1M $2.1M $5.4M $4.2M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-2.5M $-2.5M $-2.5M $-1.9M $-82.2M $20.2M $-2.3M $-14.7M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $26.6M $3.5M — — — — — —
Net Cash from Financing Activities $-51.2M $-4.8M $5.7M $-9.6M $59.9M $2.1M $2.5M $1.9M
Net Change in Cash — — — — — — — $-3.9M
Free Cash Flow $40.4M $38.3M $33.5M $3.4M $528.0K $735.0K $-2.9M $4.8M
← Newer Page 1 of 2 Older →